Page 32 - Génome Québec - 2017-2018 Annual report

ASSESSMENT OF

COMPLETED PROJECTS

(CONT’D)

Number Number of Number of Number Number of Number of
Duration of persons scientists Number of Number of declarations Duration of persons scientists Number of Number of declarations
of the project employed trained publications conferences of invention of the project employed trained publications conferences of invention
FOR 2017-2018 (pers. - years) (pers. - years) accepted as speaker or patents FOR 2017-2018 (pers. - years) (pers. - years) accepted as speaker or patents

GQ HEALTH COMPETITION COMPETITION - QUÉBEC VERT

GREGOR ANDELFINGER - CHU STE-JUSTINE FRANÇOIS BELZILE - ULAVAL
Comprehensive genomic analysis of patients 4 years 9.7 2.4 2 4 1 GreenSNPs: an enabling technology
with congenital heart disease for environmental genomics in aquatic 2 years 5.6 2 4 9 0
or land animals and plants
GUY A. ROULEAU - CHUM
Next-generation sequencing approach to identify 3 years 12.9 0.2 5 5 0 CONNIE LOVEJOY - ULAVAL
bipolar disorder genes Genomes and Transcriptomes of Arctic 1.5 year 4.2 1.2 0 3 0
Chromists (GTAC)
GUY SAUVAGEAU - UMONTRÉAL
Leucegene Project: Transcriptome sequencing 3 years 28 2.2 7 9 5 VINCENT MARTIN - UCONCORDIA
to identify novel prognostic markers and therapeutic A Platform for Automated Yeast Genome 2 years 2.6 0 0 0 0
targets in acute myeloid leukemia
Engineering (PAYGE)
JOHN H. WHITE - MCGILL
Host macrophage transcriptomic responses 3 years 15.8 6.7 5 14 0
to M. Tuberculosis infection ENTREPRENEURSHIP PROGRAM - EDUCATION IN GENOMICS
KEN DEWAR - MCGILL DENIS J. GARAND - ULAVAL
The cartography of intestinal microbial communities 3 years 18.1 5.8 3 9 0 Boosting Entrepreneurial Skills and Training: 3 years 14.1 2.3 0 17 0
in a non-human primate model system BEST in Genomics!

MARK BASIK - JEWISH GENERAL HOSPITAL
Molecular profiling of drug resistant triple 4.5 years 36.1 10.5 7 20 0
negative breast cancer GÉNOME QUÉBEC RECRUITMENT PROGRAM - HUMAN HEALTH
CARTaGENE DIRECTOR
MICHAEL HALLET - MCGILL
Next-generation predictive signatures 4 years 22.3 5 5 5 0
for breast cancer SÉBASTIEN JACQUEMONT - CHU STE-JUSTINE 5 years 65.17 0 53 42 0
CARTaGENE
ALAIN MOREAU - CHU STE-JUSTINE
Genomics of pediatric scoliosis innovation platform: 4 years 26.6 11.8 4 3 0 HUMAN HEALTH
from genes to comprehensive diagnostic assays
MARK LATHROP - MCGILL
MICHEL G. BERGERON - ULAVAL 5 years 39.98 5.62 36 0 0
Simple microfluidic system for rapid and robust Medical genomics
identification of pathogens by real-time PCR 2 years 12 1 0 8 1
at point-of-care MIKE TYERS - UMONTRÉAL 6 years 88.42 19.62 53 37 4
Biological network in human health
MARYAM TABRIZIAN - MCGILL
Portable SPR-based digital microfluidic 4 years 17.7 6.7 15 19 0
array platform
PAUL GOODYER - RESEARCH INSTITUTE
OF THE MUHC 3 years 18.1 7.1 1 10 0
Cell therapy of cystinosis
PAVEL HAMET - CHUM
Development of a predictive tool for micro 3.5 years 27.4 5.7 0 22 6
and macrovascular complications in patients
with Type 2 Diabetes
GORDON SHORE - MCGILL
MICHEL L. TREMBLAY - MCGILL 3.5 years 18.3 2.7 0 6 1
032 Therapeutic development platform: targeting 2017-2018 ANNUAL REPORT
metabolism in cancer therapy